Karin L. Klingman

Medicine · Health Sciences

28h-index4.0kcitations87works19.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS Research and Interventions(52), HIV Research and Treatment(36), HIV/AIDS drug development and treatment(36), HIV-related health complications and treatments(24), Pneumonia and Respiratory Infections(4)

Publications85 total

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
UNC Libraries·2025· 1 citedOpen Access
Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine)
Open Forum Infectious Diseases·2024Open Access
The Effect of Open-Label Semaglutide on Metabolic Dysfunction–Associated Steatotic Liver Disease in People With HIV
Annals of Internal Medicine·2024· 25 citedOpen Access
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Clinical Infectious Diseases·2024· 11 citedOpen Access
LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial
Open Forum Infectious Diseases·2022· 2 citedOpen Access
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
BMC Infectious Diseases·2022· 5 citedOpen Access
A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
Open Forum Infectious Diseases·2021· 16 citedOpen Access
Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection
UNC Libraries·2021Open Access
Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188
UNC Libraries·2020Open Access
Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race–ethnicity determine the degree of regimen complexity
UNC Libraries·2020Open Access
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study
UNC Libraries·2020Open Access
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial
UNC Libraries·2020· 1 citedOpen Access
Quality of Life Among Individuals with HIV Starting Antiretroviral Therapy in Diverse Resource-Limited Areas of the World
UNC Libraries·2020Open Access
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
UNC Libraries·2020Open Access
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial
The Journal of Infectious Diseases·2020· 23 citedOpen Access
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum
The Journal of Infectious Diseases·2020· 6 citedOpen Access
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)
UNC Libraries·2020· 28 citedOpen Access
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir
UNC Libraries·2020· 2 citedOpen Access
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens
Clinical Infectious Diseases·2020· 10 citedOpen Access
Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination
HIV Research & Clinical Practice·2020· 10 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Judith S. Currier(11), James F. Rooney(9), Heather J. Ribaudo(8), Roy M. Gulick(7), Carl J. Fichtenbaum(7), Laura Smeaton(7), Adriana Andrade(7), Anne Coletti(6), Susan H. Eshleman(6), Sharon A. Riddler(5), Richard Haubrich(5), John W. Mellors(5), Thomas Campbell(5), Mina C. Hosseinipour(5), Craig W. Hendrix(5), Alex R. Rinehart(5), Risa M. Hoffman(5), Sean S. Brummel(5), James McIntyre(4), David E. Shapiro(4)